Haihe Biopharma
Shanghai
About Haihe Biopharma
HaiHe Biopharma is a developer of innovative anti tumor drugs designed to overcome complex diseases and improve pharmacological evaluation. The company focuses on discovery, development and commercialization of innovative anti-tumor drugs, pharmacological efficacy evaluation and provide products including novel topoisomerase I inhibitors and oral c-Met highly selective inhibitors, enabling customers to improve their health conditions and research quality in an efficient manner.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $100K – $500K
- Total funding: $317.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2020)
- Website: haihepharma.com
- Phone: 86-(021)-20568888
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/haihe-biopharma-38063 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.